Laurent Riou

Summary

Country: France

Publications

  1. ncbi Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents
    L M Riou
    INSERM, U340 Radiopharmaceutiques Biocliniques Université de Grenoble, La Tronche, France
    Eur J Nucl Med Mol Imaging 34:330-7. 2007
  2. ncbi The in vivo cardiac kinetics of Tc-99m N-NOET are accelerated in obese, hyperlipidemic Zucker rats
    Laurent M Riou
    INSERM 0340 Radiopharmaceutiques Biocliniques, Université de Grenoble, Grenoble, France
    J Nucl Cardiol 13:75-82. 2006
  3. ncbi Differential effects of cyclodextrins and derivatives on the biological behavior of the myocardial perfusion imaging agent 99mTcN-NOET
    Laurent Riou
    INSERM E0340 Radiopharmaceutiques Biocliniques, Faculte de Medecine de Grenoble, Domaine de la Merci, La Tronche, France
    Eur J Pharm Biopharm 61:40-9. 2005
  4. ncbi Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview
    L M Riou
    INSERM, U877, Radiopharmaceutiques Biocliniques, Faculte de Medecine de Grenoble, F 38700, La Tronche, France
    Curr Med Chem 16:1499-511. 2009
  5. ncbi Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model
    Mitra Ahmadi
    INSERM, Radiopharmaceutiques Biocliniques, La Tronche, France
    Cancer Biother Radiopharm 23:691-700. 2008
  6. ncbi Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium
    Laurent M Riou
    Laboratoire d'Etude de Radiopharmaceutiques, University Hospital of Grenoble, Grenoble, France
    J Nucl Med 44:981-7. 2003
  7. ncbi In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD
    Lucie Sancey
    INSERM U877, Radiopharmaceutiques Biocliniques, Faculte de Medecine, Université de Grenoble, La Tronche, France
    Eur J Nucl Med Mol Imaging 34:2037-47. 2007
  8. ncbi Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution
    Olivier Detante
    INSERM, U836, Grenoble Cedex 9, France
    Cell Transplant 18:1369-79. 2009
  9. ncbi In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD
    Julien Dimastromatteo
    INSERM U877, Radiopharmaceutiques Biocliniques, Faculte de Medecine de Grenoble, 38700 La Tronche, Grenoble, France
    J Nucl Cardiol 17:435-43. 2010
  10. ncbi Mapping elasticity moduli of atherosclerotic plaque in situ via atomic force microscopy
    Philippe Tracqui
    Laboratoire TIMC IMAG, Equipe DynaCell, CNRS UMR 5525, Institut de l Ingénierie et de l Information de Santé, Faculte de Medecine de Grenoble, 38706 La Tronche Cedex, France
    J Struct Biol 174:115-23. 2011

Collaborators

Detail Information

Publications17

  1. ncbi Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents
    L M Riou
    INSERM, U340 Radiopharmaceutiques Biocliniques Université de Grenoble, La Tronche, France
    Eur J Nucl Med Mol Imaging 34:330-7. 2007
    ..We compared the myocardial uptake of diffusible ((201)Tl) and deposited ((99m)TcN-NOET) perfusion imaging agents in the setting of experimental infarction...
  2. ncbi The in vivo cardiac kinetics of Tc-99m N-NOET are accelerated in obese, hyperlipidemic Zucker rats
    Laurent M Riou
    INSERM 0340 Radiopharmaceutiques Biocliniques, Université de Grenoble, Grenoble, France
    J Nucl Cardiol 13:75-82. 2006
    ..We sought to determine whether the myocardial kinetics of Tc-99m N-NOET were affected by hyperlipidemia in a clinically relevant experimental model...
  3. ncbi Differential effects of cyclodextrins and derivatives on the biological behavior of the myocardial perfusion imaging agent 99mTcN-NOET
    Laurent Riou
    INSERM E0340 Radiopharmaceutiques Biocliniques, Faculte de Medecine de Grenoble, Domaine de la Merci, La Tronche, France
    Eur J Pharm Biopharm 61:40-9. 2005
    ..Moreover, the in vitro and ex vivo biological behavior of (99m)TcN-NOET was greatly affected depending on the CD used for inclusion of the tracer...
  4. ncbi Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview
    L M Riou
    INSERM, U877, Radiopharmaceutiques Biocliniques, Faculte de Medecine de Grenoble, F 38700, La Tronche, France
    Curr Med Chem 16:1499-511. 2009
    ..The experimental and pilot clinical studies reviewed in the present paper represent a fundamental step prior to the evaluation of the efficacy of any selected tracer for the early, non-invasive detection of vulnerable patients...
  5. ncbi Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model
    Mitra Ahmadi
    INSERM, Radiopharmaceutiques Biocliniques, La Tronche, France
    Cancer Biother Radiopharm 23:691-700. 2008
    ..Whole-body noninvasive planar imaging allowed tumor visualization from 1 hour postinjection. However, renal uptake must be reduced to increase the therapeutic potential of RAFT-RGD...
  6. ncbi Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium
    Laurent M Riou
    Laboratoire d'Etude de Radiopharmaceutiques, University Hospital of Grenoble, Grenoble, France
    J Nucl Med 44:981-7. 2003
    ..These results suggest that verapamil should not affect (99m)TcN-NOET myocardial uptake in patients referred for myocardial perfusion imaging...
  7. ncbi In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD
    Lucie Sancey
    INSERM U877, Radiopharmaceutiques Biocliniques, Faculte de Medecine, Université de Grenoble, La Tronche, France
    Eur J Nucl Med Mol Imaging 34:2037-47. 2007
    ..We evaluated the potential of the novel radiotracer (99m)Tc-RAFT-RGD for the non-invasive molecular imaging of alpha(v)beta(3) integrin expression in mice models of tumour development...
  8. ncbi Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution
    Olivier Detante
    INSERM, U836, Grenoble Cedex 9, France
    Cell Transplant 18:1369-79. 2009
    ..After 20 h, more hMSC are found in the ischemic lesion than into the undamaged cerebral tissue. IV delivery of hMSC could be the initial route for a clinical trial of tolerance...
  9. ncbi In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD
    Julien Dimastromatteo
    INSERM U877, Radiopharmaceutiques Biocliniques, Faculte de Medecine de Grenoble, 38700 La Tronche, Grenoble, France
    J Nucl Cardiol 17:435-43. 2010
    ..99m)Tc-RAFT-RGD is a novel (99m)Tc-labeled tracer that targets the alpha(v)beta(3) integrin. Our objective was to determine whether this tracer was suitable for myocardial angiogenesis imaging...
  10. ncbi Mapping elasticity moduli of atherosclerotic plaque in situ via atomic force microscopy
    Philippe Tracqui
    Laboratoire TIMC IMAG, Equipe DynaCell, CNRS UMR 5525, Institut de l Ingénierie et de l Information de Santé, Faculte de Medecine de Grenoble, 38706 La Tronche Cedex, France
    J Struct Biol 174:115-23. 2011
    ....
  11. ncbi Assessing low levels of mechanical stress in aortic atherosclerotic lesions from apolipoprotein E-/- mice--brief report
    Alexis Broisat
    INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
    Arterioscler Thromb Vasc Biol 31:1007-10. 2011
    ....
  12. ncbi Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses
    Kengo Hatada
    Second Department of Internal Medicine, Cardiovascular Division, Kansai Medical University Takii Hospital Moriguchi City, Osaka, Japan
    J Nucl Cardiol 13:779-90. 2006
    ....
  13. ncbi Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium
    David K Glover
    Department of Internal Medicine, Division of Cardiology, University of Virginia, PO Box 800500, UVA Health System, Cobb Hall, Rm 1010, Hospital Drive, Charlottesville, VA 22908 0500, USA
    Am J Physiol Heart Circ Physiol 288:H1851-8. 2005
    ..Such combination therapy may be beneficial clinically by potentiating cardioprotection after coronary reperfusion at doses far below those producing vasodilatation or side effects...
  14. ncbi Effects of increased lipid concentration and hyperemic blood flow on the intrinsic myocardial washout kinetics of (99m)TcN-NOET
    Laurent M Riou
    Cardiovascular Division, University of Virginia Health System, Charlottesville, Virginia 22908-0500, USA
    J Nucl Med 44:1092-8. 2003
    ..The potential impact of variations in circulating lipid levels among patients on clinical imaging with (99m)TcN-NOET requires further investigation...
  15. ncbi Assessment of myocardial inflammation produced by experimental coronary occlusion and reperfusion with 99mTc-RP517, a new leukotriene B4 receptor antagonist that preferentially labels neutrophils in vivo
    Laurent M Riou
    University of Virginia Health System, Charlottesville, VA 22908-0500, USA
    Circulation 106:592-8. 2002
    ..After reperfusion, 99mTc-RP517 uptake correlated with myeloperoxidase and was observed on ex vivo images, indicating that this tracer may have potential as an inflammation-imaging agent...
  16. ncbi 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats
    Kengo Hatada
    Experimental Cardiology Laboratory, Cardiovascular Division, Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia, USA
    J Nucl Med 45:2095-101. 2004
    ....
  17. ncbi Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation
    Laurent M Riou
    Cardiovascular Division, University of Virginia Health System, Charlottesville, VA 22908-0500, USA
    J Am Coll Cardiol 40:1687-94. 2002
    ....